false 2026 Q2 --08-31 0001071840 0001071840 2025-09-01 2026-02-28 0001071840 2026-04-09 0001071840 2026-02-28 0001071840 2025-08-31 0001071840 2025-12-01 2026-02-28 0001071840 2024-12-01 2025-02-28 0001071840 2024-09-01 2025-02-28 0001071840 us-gaap:CommonStockMember 2025-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2025-08-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-08-31 0001071840 us-gaap:RetainedEarningsMember 2025-08-31 0001071840 us-gaap:CommonStockMember 2025-11-30 0001071840 us-gaap:AdditionalPaidInCapitalMember 2025-11-30 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-11-30 0001071840 us-gaap:RetainedEarningsMember 2025-11-30 0001071840 2025-11-30 0001071840 us-gaap:CommonStockMember 2024-08-31 0001071840 us-gaap:AdditionalPaidInCapitalMember 2024-08-31 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-08-31 0001071840 us-gaap:RetainedEarningsMember 2024-08-31 0001071840 2024-08-31 0001071840 us-gaap:CommonStockMember 2024-11-30 0001071840 us-gaap:AdditionalPaidInCapitalMember 2024-11-30 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-11-30 0001071840 us-gaap:RetainedEarningsMember 2024-11-30 0001071840 2024-11-30 0001071840 us-gaap:CommonStockMember 2025-09-01 2025-11-30 0001071840 us-gaap:AdditionalPaidInCapitalMember 2025-09-01 2025-11-30 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-01 2025-11-30 0001071840 us-gaap:RetainedEarningsMember 2025-09-01 2025-11-30 0001071840 2025-09-01 2025-11-30 0001071840 us-gaap:CommonStockMember 2025-12-01 2026-02-28 0001071840 us-gaap:AdditionalPaidInCapitalMember 2025-12-01 2026-02-28 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-01 2026-02-28 0001071840 us-gaap:RetainedEarningsMember 2025-12-01 2026-02-28 0001071840 us-gaap:CommonStockMember 2024-09-01 2024-11-30 0001071840 us-gaap:AdditionalPaidInCapitalMember 2024-09-01 2024-11-30 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-01 2024-11-30 0001071840 us-gaap:RetainedEarningsMember 2024-09-01 2024-11-30 0001071840 2024-09-01 2024-11-30 0001071840 us-gaap:CommonStockMember 2024-12-01 2025-02-28 0001071840 us-gaap:AdditionalPaidInCapitalMember 2024-12-01 2025-02-28 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-01 2025-02-28 0001071840 us-gaap:RetainedEarningsMember 2024-12-01 2025-02-28 0001071840 us-gaap:CommonStockMember 2026-02-28 0001071840 us-gaap:AdditionalPaidInCapitalMember 2026-02-28 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-02-28 0001071840 us-gaap:RetainedEarningsMember 2026-02-28 0001071840 us-gaap:CommonStockMember 2025-02-28 0001071840 us-gaap:AdditionalPaidInCapitalMember 2025-02-28 0001071840 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-02-28 0001071840 us-gaap:RetainedEarningsMember 2025-02-28 0001071840 2025-02-28 0001071840 wndw:StockOptionsMember 2025-12-01 2026-02-28 0001071840 wndw:StockOptionsMember 2024-12-01 2025-02-28 0001071840 wndw:StockOptionsMember 2025-09-01 2026-02-28 0001071840 wndw:StockOptionsMember 2024-09-01 2025-02-28 0001071840 wndw:WarrantsMember 2025-12-01 2026-02-28 0001071840 wndw:WarrantsMember 2024-12-01 2025-02-28 0001071840 wndw:WarrantsMember 2025-09-01 2026-02-28 0001071840 wndw:WarrantsMember 2024-09-01 2025-02-28 0001071840 us-gaap:OfficeEquipmentMember 2026-02-28 0001071840 us-gaap:OfficeEquipmentMember 2025-08-31 0001071840 us-gaap:EquipmentMember 2026-02-28 0001071840 us-gaap:EquipmentMember 2025-08-31 0001071840 wndw:SeriesTMember 2026-02-28 0001071840 wndw:SeriesTMember 2025-08-31 0001071840 wndw:SeriesTMember 2025-09-01 2026-02-28 0001071840 wndw:SeriesUMember 2026-02-28 0001071840 wndw:SeriesUMember 2025-08-31 0001071840 wndw:SeriesUMember 2025-09-01 2026-02-28 0001071840 wndw:SeriesUOSMember 2026-02-28 0001071840 wndw:SeriesUOSMember 2025-08-31 0001071840 wndw:SeriesUOSMember 2025-09-01 2026-02-28 0001071840 us-gaap:StockOptionMember 2026-02-28 0001071840 us-gaap:StockOptionMember 2025-09-01 2026-02-28 0001071840 wndw:ExercisePriceOneMember 2026-02-28 0001071840 wndw:ExercisePriceOneMember 2025-09-01 2026-02-28 0001071840 wndw:ExercisePriceTwoMember 2026-02-28 0001071840 wndw:ExercisePriceTwoMember 2025-09-01 2026-02-28 0001071840 wndw:ExercisePriceThreeMember 2026-02-28 0001071840 wndw:ExercisePriceThreeMember 2025-09-01 2026-02-28 0001071840 wndw:ExercisePriceFourMember 2026-02-28 0001071840 wndw:ExercisePriceFourMember 2025-09-01 2026-02-28 0001071840 wndw:ExercisePriceFiveMember 2026-02-28 0001071840 wndw:ExercisePriceFiveMember 2025-09-01 2026-02-28 0001071840 wndw:ExercisePriceSixMember 2026-02-28 0001071840 wndw:ExercisePriceSixMember 2025-09-01 2026-02-28 0001071840 wndw:ExercisePriceSevenMember 2026-02-28 0001071840 wndw:ExercisePriceSevenMember 2025-09-01 2026-02-28 0001071840 wndw:SierchioLawLLPMember 2026-02-28 0001071840 wndw:SierchioLawLLPMember 2025-09-01 2026-02-28 0001071840 wndw:SierchioLawLLPMember 2025-08-31 0001071840 wndw:SierchioLawLLPMember 2025-06-01 2025-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2026

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission file number 333-127953

SOLARWINDOW TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Nevada		59-3509694
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

9375 E. Shea Blvd., Suite 107-B
Scottsdale, AZ		85260
(Address of principal executive offices)		(Zip Code)

(800) 213-0689

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in 12b-2 of the Exchange Act).

Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act: None

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 65,779,045 shares of common stock, par value $0.001, were outstanding on April 9, 2026.

SOLARWINDOW TECHNOLOGIES, INC.

FORM 10-Q

For the Quarterly Period Ended February 28, 2026

Table of Contents

PART I FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements	1

Consolidated Balance Sheets	1

Consolidated Statements of Operations and Comprehensive Loss	2

Consolidated Statements of Stockholders’ Equity	3

Consolidated Statements of Cash Flows	4

Notes to Consolidated Financial Statements	5

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	10

Item 3. Quantitative and Qualitative Disclosures About Market Risk	14

Item 4. Controls and Procedures	14

PART II OTHER INFORMATION

Item 1A. Risk Factors	15

Item 6. Exhibits	15

Signatures	16

Certifications

PART I — FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

SOLARWINDOW TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS


	February 28,			August 31,
	2026			2025
ASSETS		(Unaudited)
Current assets
Cash and cash equivalents	$	5,391,821		$	6,555,642
Deferred research and development costs		34,274			30,687
Prepaid expenses and other current assets		79,028			15,836
Total current assets		5,505,123			6,602,165
Property and Equipment, net		64,167			43,089
Total assets		5,569,290		$	6,645,254

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities
Accounts payable and accrued expenses	$	187,688		$	114,309
Related party payables		90,701			79,866
Total current liabilities		278,389			194,175
Total liabilities		278,389			194,175

Commitments and contingencies

Stockholders' equity
Preferred stock: $0.10 par value; 1,000,000 shares authorized, no shares issued and outstanding		-			-
Common stock: $0.001 par value; 300,000,000 shares authorized, 65,779,045 shares issued and outstanding at February 28, 2026 and August 31, 2025		65,779			65,779
Additional paid-in capital		87,475,862			87,475,862
Accumulated deficit		(82,250,740	)		(81,090,562	)
Total stockholders' equity		5,290,901			6,451,079
Total liabilities and stockholders' equity	$	5,569,290		$	6,645,254

(The accompanying notes are an integral part of these consolidated financial statements)

SOLARWINDOW TECHNOLOGIES, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)


	Three Months Ended February 28,						Six Months Ended February 28,
	2026			2025			2026			2025

Revenue	$	-		$	-		$	-		$	-

Operating expenses:
Selling, general and administrative		453,311			495,692			917,648			953,644
Research and development		170,635			173,335			319,486			310,514
Total operating expenses		623,946			669,027			1,237,134			1,264,158
Loss from operations		(623,946	)		(669,027	)		(1,237,134	)		(1,264,158	)

Other income:
Interest income		34,526			38,983			76,958			83,022
Total other income		34,526			38,983			76,958			83,022
Net loss from continuing operations		(589,420	)		(630,044	)		(1,160,176	)		(1,181,136	)
Net loss from discontinued operations		-			(24,043	)		-			(25,014	)
Net loss attributable to common stockholders		(589,420	)		(654,087	)		(1,160,176	)		(1,206,150	)
Other comprehensive income (loss):
Foreign currency translation gain/(loss)		-			2,368			-			4,669
Comprehensive (loss) attributable to common stockholders’		(589,420	)	$	(651,719	)		(1,160,176	)	$	(1,201,481	)

Loss per Share from continuing operations basic and diluted	$	(0.01	)	$	(0.01	)	$	(0.02	)	$	(0.02	)
Loss per Share from discontinued operations basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Net loss attributable to common stockholders per share basic and diluted	$	(0.01	)	$	(0.01	)	$	(0.02	)	$	(0.02	)

Weighted average number of common shares outstanding - basic and diluted		65,779,045			53,198,399			65,779,045			53,198,399

(The accompanying notes are an integral part of these consolidated financial statements)

SOLARWINDOW TECHNOLOGIES, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)


					Additional		Accumulated Other						Total
FOR THE SIX MONTHS ENDED FEBRUARY 28, 2026	Common Stock				Paid-in		Comprehensive			Retained			Stockholders'
	Shares		Amount		Capital		Income (Loss)			Deficit			Equity
Balance, August 31, 2025		65,779,045	$	65,779	$	87,475,862	$	-		$	(81,090,562	)	$	6,451,079
Net loss		-		-		-		-			(570,758	)		(570,758	)
Balance, November 30, 2025		65,779,045		65,779		87,475,862		-			(81,661,320	)		5,880,321
Net Loss		-		-		-		-			(589,420	)		(589,420	)
Balance, February 28, 2026		65,779,045	$	65,779	$	87,475,862	$	-		$	(82,250,740	)	$	5,290,901

FOR THE SIX MONTHS ENDED FEBRUARY 28, 2025
Balance, August 31, 2024		53,198,399	$	53,198	$	83,538,904	$	(76,702	)	$	(78,833,284	)	$	4,682,116
Stock based compensation due to common stock purchase options		-		-		51,563		-			-			51,563
Foreign currency translation adjustment		-		-		-		2,301			-			2,301
Net loss		-		-		-		-			(552,063	)		(552,063	)
Balance, November 30, 2024		53,198,399		53,198		83,590,467		(74,401	)		(79,385,347	)		4,183,917
Stock based compensation due to common stock purchase options		-		-		51,562		-			-			51,562
Foreign currency translation adjustment		-		-		-		2,368			-			2,368
Net loss		-		-		-		-			(654,087	)		(654,087	)
Balance, February 28, 2025		53,198,399	$	53,198	$	83,642,029	$	(72,033	)	$	(80,039,434	)	$	3,583,760

(The accompanying notes are an integral part of these consolidated financial statements)

SOLARWINDOW TECHNOLOGIES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)


	Six Months Ended February 28,
	2026			2025
Cash flows from operating activities
Net loss from continuing operations	$	(1,160,176	)	$	(1,181,136	)
Net loss from discontinued operations		-			(25,014	)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation		8,786			3,146
Stock based compensation expense		-			103,125
Changes in operating assets and liabilities:
Deferred research and development costs		(3,587	)		(18,039	)
Prepaid expenses and other assets		(63,192	)		624,233
Accounts payable and accrued expenses		73,377			4,402
Related party payable		10,835			37,357
Net cash used in operating activities		(1,133,957	)		(451,926	)

Cash flows from investing activities
Redemption of short-term investments		-			3,000,000
Capital expenditures		(29,864	)		-
Net cash provided by investing activities		(29,864	)		3,000,000
Net increase in cash and cash equivalents		(1,163,821	)		2,548,074
Cash and cash equivalents at beginning of period		6,555,642			1,249,446
Cash and cash equivalents at end of period	$	5,391,821		$	3,797,520

(The accompanying notes are an integral part of these consolidated financial statements)

SOLARWINDOW TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 – Organization

Organization

SolarWindow Technologies, Inc. was incorporated in the State of Nevada on May 5, 1998 (the “Company”). SolarWindow® technology harvests light energy from the sun and from artificial light sources using a transparent and ultra-lightweight coating of organic photovoltaic (“OPV”) solar cells applied to glass and plastics, thereby generating electricity. The Company’s ticker symbol is WNDW.

Liquidity

The Company has not generated any revenue since inception and has sustained recurring losses and negative cash flows from operations since inception. We expect to incur losses as we continue to develop and further refine and promote our technologies and potential product applications. As of February 28, 2026, the Company had $5,392,000 of cash on hand, and working capital of $5,226,000. The Company believes that it currently has sufficient cash to meet its funding requirements over the next twelve months following the issuance of this Quarterly Report on Form 10-Q. However, the Company has experienced and continues to experience negative cash flows from operations, as well as an ongoing requirement for additional capital investment. The Company expects that it will need to raise additional capital to commercialize its electricity generating coatings and application methodology. The Company expects to seek to obtain that funding through financial or strategic investors. There can be no assurance as to the availability of such financings nor is it possible to determine at this time the terms and conditions upon which such financing and capital might be available.

NOTE 2 – Interim Statement Presentation

Basis of Presentation and Use of Estimates

The accompanying unaudited interim consolidated financial statements of the Company as of February 28, 2026, and for the three and six months ended February 28, 2026 and 2025 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q and do not include all of the information and note disclosures required by U.S. generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. These Consolidated Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and Notes thereto for the fiscal year ended August 31, 2025, included in our Annual Report on Form 10-K filed with the SEC on November 13, 2025.

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the accounting period. Actual results may differ from those estimates. The accompanying unaudited interim consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments (including normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company’s consolidated financial position as of February 28, 2026, results of operations, stockholders’ equity and cash flows for the three and six months ended February 28, 2026 and 2025. The Company did not record an income tax provision during the periods presented due to net taxable losses. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year.

These consolidated financial statements presented are those of the Company. For the three and six months ended February 28, 2025, the Company recognized $24,043 and $25,014, respectively, of loss from its wholly owned subsidiaries, SolarWindow Asia (USA) Corp., and SolarWindow Asia Co. Ltd., which entities have been dissolved as of the beginning of fiscal 2026. All significant intercompany balances and transactions have been eliminated.

Information regarding the Company’s significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended August 31, 2025. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Condensed Consolidated Financial Statements” in the Annual Report.

Fiscal quarter

The Company’s quarterly periods end on November 30, February 28, May 31, and August 31. The Company’s second quarter in fiscal 2026 and 2025 ended on February 28, 2026 and February 28, 2025, respectively.

Net Income (Loss) Per Share

The computation of basic earnings per share (“EPS”) is based on the weighted average number of shares that were outstanding during the period, including shares of common stock that are issuable at the end of the reporting period. The computation of diluted EPS is based on the number of basic weighted-average shares outstanding plus the number of common shares that would be issued assuming the exercise of all potentially dilutive common shares outstanding using the treasury stock method. The computation of diluted net income per share does not assume conversion, exercise or contingent issuance of securities that would have an antidilutive effect on earnings per share. Therefore, when calculating EPS if the Company experienced a loss, there is no inclusion of dilutive securities as their inclusion in the EPS calculation is antidilutive. Furthermore, options and warrants will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options or warrants (they are in the money).

The shares listed below were not included in the computation of diluted losses per share because to do so would be antidilutive for the periods presented:


	Three Months Ended February 28,				Six Months Ended February 28,
	2026		2025		2026		2025
Stock options		5,206,000		5,433,000		5,206,000		5,433,000
Warrants		29,247,313		16,666,667		29,247,313		16,666,667
		34,453,313		22,099,667		34,453,313		22,099,667

Accounting Pronouncements

We evaluate all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board for consideration of their applicability. ASUs not included in our disclosures were assessed and determined to be either not applicable or are not expected to have a material impact on our unaudited condensed financial statements.

Recently Adopted Accounting Pronouncements

In November 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). ASU 2023-07 expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, which means ASU 2023-07 is effective for our annual periods beginning September 1, 2024, and our interim periods beginning September 1, 2025, or our current fiscal year which began on September 1, 2025. The Company adopted the ASU 2023-07 and determined that its adoption did not have a material impact on the Company’s financial statements and related disclosures.

Recently Issued Accounting Pronouncements

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses. This new guidance is designed to improve the disclosures about the types of expenses, including employee compensation, depreciation, and amortization, and costs incurred related to inventory and manufacturing activities. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027 on a prospective basis with optional retrospective application. Early adoption is permitted. The Company is currently assessing the impact of this guidance on its disclosures.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the annual income tax disclosures for the effective tax rate reconciliation and income taxes paid. ASU 2023-09 is effective for our annual reporting periods beginning September 1, 2026, with early adoption permitted. The Company is currently assessing the impact of this guidance on its disclosures.

NOTE 3 – Property and Equipment

Property and equipment consists of the following:

Schedule of Property and equipment
	February 28,			August 31,
	2026			2025
Computers, office equipment and software	$	26,780		$	25,525
R&D Equipment		190,475			161,866
Total property and equipment		217,254			187,391
Accumulated depreciation		(153,088	)		(144,302	)
Property and equipment, net	$	64,167		$	43,089

During the three months ended February 28, 2026 and 2025, the Company recognized straight-line depreciation expense of $4,888 and $1,501, respectively. During the six months ended February 28, 2026 and 2025, the Company recognized straight-line depreciation expense of $8,786 and $3,146, respectively.

NOTE 4 – Common Stock and Warrants

Common Stock

At February 28, 2026, the Company had 300,000,000 authorized shares of common stock with a par value of $0.001 per share, and 65,779,045 shares of common stock outstanding.

Warrants

Each of the Company’s warrants outstanding entitles the holder to purchase one share of the Company’s common stock for each warrant share held. The Series T Warrants may be exercised on a cashless basis. A summary of the Company’s warrants outstanding and exercisable as of February 28, 2026 and August 31, 2025:


	Shares of Common Stock Issuable from Warrants Outstanding as of			Weighted Average
Description	February 28, 2026	August 31, 2025		Exercise Price	Date of Issuance	Expiration
Series T Warrants	16,666,667	16,666,667	$	1.70	November 26, 2018	November 26, 2029
Series U Warrants	4,516,130	4,516,130	$	0.47	June 16, 2025	June 16, 2028
Series U-OS Warrants	8,064,516	8,064,516	$	0.47	June 16, 2025	June 16, 2028
Total	29,247,313	29,247,313

NOTE 5 - Stock Options

The Company measures share-based compensation cost on the grant date, based on the fair value of the award, and recognizes the expense on a straight-line basis over the requisite service period for awards expected to vest. The Company estimates the grant date fair value of stock options using a Black-Scholes valuation model. No stock options were granted during the six months ended February 28, 2026 and 2025. A summary of the Company’s stock option activity for the six months ended February 28, 2026 and related information follows:

Schedule of stock option activity
	Number of Shares Subject to Option Grants		Weighted Average Exercise Price ($)		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value ($)
Outstanding at February 28, 2026		5,206,000		2.37		3.04		37,500
Exercisable at February 28, 2026		5,206,000		2.37		3.04		37,500

The aggregate intrinsic value in the table above represents the total pretax intrinsic value for all “in-the-money” options (i.e. the difference between the Company’s closing stock price on the last trading day of the period covered by this report and the exercise price, multiplied by the number of shares) that would have been received by the option holders had all in-the-money option holders exercised their vested options on February 28, 2026. The intrinsic value of the option changes based upon the fair market value of the Company’s common stock. Since the closing stock price was $0.36 on February 28, 2026 and 1,250,000 outstanding options have an exercise price below $0.36 per share, as of February 28, 2026, there is $37,500 of intrinsic value to the Company’s vested stock options.

The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Statements of Operations for the three and six months ended February 28, 2026 and 2025:

Schedule of share-based compensation
	Three Months Ended February 28,				Six Months Ended February 28,
	2026		2025		2026		2025
Stock compensation expense:
Selling, general and administrative	$	-	$	51,562	$	-	$	103,125

The following table summarizes information about stock options outstanding and exercisable at February 28, 2026:

Schedule of Stock Options Outstanding
	Stock Options Outstanding			Stock Options Exercisable
Range of Exercise Prices	Number of Shares Subject to Outstanding Options	Weighted Average Contractual Life (years)	Weighted Average Exercise Price ($)	Number of Shares Subject To Options Exercise	Weighted Average Remaining Contractual Life (Years)	Weighted Average Exercise Price ($)
0.33	1,250,000	3.11	0.33	1,250,000	3.11	0.33
2.32	153,000	3.62	2.32	153,000	3.62	2.32
2.60	2,500,000	2.94	2.60	2,500,000	2.94	2.60
3.42	50,000	0.64	3.42	50,000	0.64	3.42
3.54	1,033,000	2.94	3.54	1,033,000	2.94	3.54
4.87	110,000	2.72	4.87	110,000	2.72	4.87
6.21	110,000	5.67	6.21	110,000	5.67	6.21
Total	5,206,000	3.04	2.37	5,206,000	3.04	2.37

NOTE 6 - Transactions with Related Persons

A related party with respect to the Company is generally defined as any person (i) (and, if a natural person, inclusive of his or her immediate family) that holds 10% or more of the Company’s securities, (ii) that is part of the Company’s management, (iii) that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

Joseph Sierchio, one of the Company’s directors, has maintained his role as the Company’s general counsel since 2005. Currently, Mr. Sierchio, as principal of Sierchio Law, LLP, serves as the Company’s general counsel on an hourly basis at the rate of $750 per hour. Fees for legal services billed by Sierchio Law, LLP totaled approximately $68,425 and $75,000 for the three months ended February 28, 2026 and 2025, respectively, and $142,825 and $136,700 for the six months ended February 28, 2026 and 2025, respectively. As of February 28, 2026, the Company recognized a related party payable to Sierchio Law, LLP of $70,925, including $68,425 related to legal services and $2,500 related to the quarterly board fee for the three months ended February 28, 2026. As of August 31, 2025, the Company recognized a related party payable to Sierchio Law, LLP of $54,625, including $52,125 related to legal services and $2,500 related to the quarterly board fee for the three months ended August 31, 2025.

All related party transactions are recorded at the exchange amount established and agreed to between related parties and are in the normal course of business.

NOTE 9 – Subsequent Events

Management has reviewed material events subsequent of the period ended February 28, 2026 and through the date of filing of financial statements in accordance with FASB ASC 855 “Subsequent Events”. In managements opinion, no material subsequent events have occurred as of the date of this quarterly report.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Report on Form 10-Q contains forward-looking statements which involve assumptions and describe our future plans, strategies, and expectations, and are generally identifiable by use of words such as “may,” “will,“ “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project,” or the negative of these words or other variations on these words or comparable terminology. These statements are expressed in good faith and based upon a reasonable basis when made, but there can be no assurance that these expectations will be achieved or accomplished.

Such forward-looking statements include statements regarding, among other things, (a) the potential markets for our technologies, our potential profitability, and cash flows, (b) our growth strategies, (c) expectations from our ongoing research and development activities, (d) anticipated trends in the technology industry, (e) our future financing plans, and (f) our anticipated needs for working capital. This information may involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from the future results, performance, or achievements expressed or implied by any forward-looking statements. These statements may be found under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as in this Form 10-Q generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including, without limitation, the matters described in this Form 10-Q generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. In addition to the information expressly required to be included in this filing, we will provide such further material information, if any, as may be necessary to make the required statements, in light of the circumstances under which they are made, not misleading.

Although forward-looking statements in this report reflect the good faith judgment of our management, forward-looking statements are inherently subject to known and unknown risks, business, economic and other risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, other than as may be required by applicable law or regulation. Readers are urged to carefully review and consider the various disclosures made by us in our filings with the Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.

Except where the context otherwise requires, and for purposes of this Form 10-Q only, the terms “we,” “us,” “our,” “Company” “our Company,” and “SolarWindow” refer to SolarWindow Technologies, Inc., a Nevada corporation.

Overview

We are a developer of semi-transparent electricity-generating coatings, and methods for their application to various materials (collectively, “LiquidElectricity® Coatings”). When applied in ultra-thin layers to rigid glass, and flexible glass and plastic surfaces our LiquidElectricity® Coatings transform otherwise ordinary surfaces into photovoltaic devices capable of generating electricity from natural sun, artificial light, and low, shaded, or reflected light conditions while maintaining transparency.

We have overcome major technical challenges and achieved many important milestones resulting in an expansion of the potential applications of LiquidElectricity® Coatings which span multiple industries, including architectural, automotive, agrivoltaic, aerospace, commercial transportation and marine. Our LiquidElectricity® Coatings are under development with support from commercial contract firms and at the U.S. Department of Energy’s National Laboratory of the Rockies (NLR), forerly known as National Renewable Energy Laboratory (NREL), through Cooperative Research and Development Agreements.

We do not currently have any commercial products and there is no assurance that we will successfully be able to design, develop, manufacture, or sell any commercial products in the future. Our product development programs involve ongoing R&D and product development efforts, and the commitment of significant resources to support the extensive invention, design, engineering, testing, prototyping, and intellectual property initiatives carried out by our contract engineers, scientists, and consultants.

We plan to market any SolarWindow® Products we commercialize through co-marketing and co-promotion, licensing, and distribution arrangements with third party collaborators, to advance the technical development and subsequent commercialization of our SolarWindow® products. We are actively seeking additional technology and product licensing, joint venture arrangements, and manufacturing process integration relationships with commercial partners and industry; and organizations which have established technical competencies, market reach, and mature distribution networks in the solar PV, building-integrated PV, and alternative and renewable energy market industries. We believe that this approach could provide immediate access to existing distribution channels which can increase market penetration and commercial acceptance of our products and enable us to avoid expending significant funds for development of a large sales and marketing organization. We have not yet entered into any such arrangements for these services.

We cannot accurately predict the amount of funding, or the time required to successfully commercialize or fabricate SolarWindow® products. The actual cost and time required to commercialize our SolarWindow® technology may vary significantly depending on, among other things, the results of our product development efforts; the cost of developing, acquiring, or licensing various enabling equipment and technologies; changes in the focus and direction of our business or product development plans; competitive and technological advances; the cost of patent filing, prosecuting, defending and enforcing claims; demonstrating compliance with regulations and standards; and manufacturing, marketing and other costs that may be associated with product fabrication. Because of this uncertainty, even if financing is available to us, we may secure insufficient funding to effectuate our business and/or product development plans.

As of February 28, 2026, we had working capital of $5,226,000 and cash of $5,392,000. Based upon current and near-term anticipated level of operations and expenditures, we believe that cash on hand should be sufficient to enable us to continue operations over the next twelve months following the issuance of this Quarterly Report on Form 10-Q.

Management recognizes that in order for us to meet our capital requirements, and continue to operate, additional financing will be necessary. We expect to raise additional funds through private or public equity investment in order to expand the range and scope of our business operations. We will seek access to private or public equity markets but there is no assurance that such additional funds will be available for us to finance our operations on acceptable terms, if at all. If we are unable to raise additional capital or generate positive cash flow, it is unlikely that we will be able to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Research and Related Agreements

We are a party to certain agreements related to the development of our technology.

Stevenson-Wydler Cooperative Research and Development Agreement with the Alliance for Sustainable Energy

On March 18, 2011, the Company and the Alliance for Sustainable Energy (“ASE”), the operator of the National Laboratory of the Rockies (“NLR”), formerly known as National Renewable Energy Laboratories (“NREL”) under its U.S. Department of Energy contract, entered into a Cooperative Research and Development Agreement (“CRADA”) to advance the commercial development of our technology, and on March 6, 2013, the Company and ASE entered into Phase II of the CRADA (collectively, the “NREL CRADA”). Under terms of the NREL CRADA, NREL researchers make use of our exclusive intellectual property (“IP”), newly developed IP, and NREL’s background IP in order to work towards specific product development goals established by the Company. Under the terms of the NREL CRADA, we agreed to reimburse Alliance for Sustainable Energy for filing fees associated with all documented, out-of-pocket costs directly related to patent application preparation and filings, and maintenance of the patent applications. Beginning in 2013, under the NREL CRADA, researchers have and will continue to work to:

•

improve our technology efficiency and transparency;

•

optimize electrical power (current and voltage) output;

•

optimize the application of the active layer coatings and application processes which make it possible for LiquidElectricity® Coatings to generate electricity on glass surfaces;

•

develop improved electricity-generating coatings by enhancing performance, processing, reliability, and durability;

•

optimize LiquidElectricity® Coating performance on flexible substrates; and

•

develop high speed and large area roll-to-roll (R2R) and sheet-to-sheet coating application methods required for commercial-scale building integrated photovoltaic products and windows.

Over the course of our collaborative research and development efforts under the NREL CRADA, both parties have agreed to modifications to extend the period of performance. The current modification extends the period of performance to December 31, 2028. As of February 28, 2026, the Company had a capitalized asset balance of $34,274 related to deferred research and development costs for advances to Alliance for Sustainable Energy for work to be performed under the NREL CRADA.

Results of Operations

Three and six months ended February 28, 2026, compared to the three and six months ended February 28, 2025

A summary of our operating expenses for the three and six months ended February 28, 2026, and 2025 follows:

						2026 compared to 2025
		Three Months Ended February 28,				Increase /		Percentage
		2026		2025		(Decrease)		Change
Operating expenses:
Selling, general & administrative	$	453,311	$	444,130	$	9,181		-2	%
Research and development		170,635		173,335		(2,700	)	-2	%
Stock compensation		-		51,562		(51,562	)	-100	%
Total Operating expenses	$	623,946	$	669,027	$	(45,081	)	-7	%

						2026 compared to 2025
		Six Months Ended February 28,				Increase /		Percentage
		2026		2025		(Decrease)		Change
Operating expenses:
Selling, general & administrative	$	917,648	$	850,519	$	67,129		8	%
Research and development		319,486		310,514		8,972		3	%
Stock compensation		-		103,125		(103,125	)	-100	%
Total Operating expense	$	1,237,134	$	1,264,158	$	(27,024	)	-2	%

Selling, General and Administrative

Selling, general and administrative (“SG&A”) costs include all expenditures incurred other than research and development related costs, including costs related to personnel, professional fees, travel, public company costs, insurance, and other office related costs. During the three months ended February 28, 2026 compared to the three months ended February 28, 2025, SG&A remained flat. During the six months ended February 28, 2026, compared to the six months ended February 28, 2025, SG&A costs increased by $67,129 primarily due to higher personnel costs ($21,000), travel costs ($16,000), professional fees ($9,000), and other SG&A costs ($16,000).

Research and Product Development

Research and Development (“R&D”) costs represent costs incurred to develop our SolarWindow® technology and are incurred pursuant to our research agreements and agreements with other third-party providers and certain internal R&D cost allocations. Payments under these agreements include salaries and benefits for R&D personnel, allocated overhead, contract services and other costs. R&D costs are expensed when incurred, except for non-refundable advance payments for future research and development activities which are capitalized and recognized as expense as the related services are performed. During the three months ended February 28, 2026, compared to the three months ended February 28, 2025, R&D costs remained flat. During the six months ended February 28, 2026 compared to the six months ended February 28, 2025, R&D costs increased primarily as a result of an increase in NREL and consultant costs ($21,000) and asset depreciation ($4,000) offset by lower R&D supplies costs ($16,000).

Stock Based Compensation

The Company grants stock options to its directors, employees and consultants. Stock compensation represents the expense associated with the amortization of our stock options. Expense associated with equity-based transactions is calculated and expensed in our financial statements as required pursuant to various accounting rules and is non-cash in nature. Stock based compensation expense decreased to zero during the three and six months ended February 28, 2026 compared to the three months ended February 28, 2025 due to full vesting of all outstanding grants.

Net loss from continuing operations

Consolidated net loss from continuing operations decreased $40,624 to $589,420 for the three months ended February 28, 2026, as compared to a net loss from continuing operations of $630,044 for the three months ended February 28, 2025. Consolidated net loss from continuing operations decreased $20,960 to $1,160,176 for the six months ended February 28, 2026, as compared to a net loss from continuing operations of $1,181,136 for the six months ended February 28, 2025. The decrease for the three-and six-month periods is primarily due to lower stock based compensation offset by higher costs related to R&D, personnel, travel and other SG&A costs.

Liquidity and Capital Resources

Our primary cash needs are for personnel, professional, R&D related fees and other administrative costs. Our principal source of liquidity is cash. As of February 28, 2026 and August 31, 2025, the Company had cash of $5,392,000 and $6,556,000, respectively. We have financed our operations primarily from the sale of equity and debt securities.

The following table presents a summary of our cash flows for the periods indicated:

		Six Months Ended February 28,						2026 compared
		2026			2025			to 2025
Net cash used in operating activities	$	(1,133,957	)	$	(451,926	)	$	(682,031	)
Net cash provided by (used in) investing activities		(29,864	)		3,000,000			(3,029,864	)
Net increase (decrease) in cash and cash equivalents	$	(1,163,821	)	$	2,548,074		$	(3,711,895	)

Operating Activities - Operating activities consist of net loss adjusted for certain non-cash items, including depreciation, stock-based compensation expense, and the effect of changes in working capital. The amount of cash used during the six months ended February 28, 2026 compared to cash used during the six months ended February 28, 2025 increased $682,031 due primarily to the absence in the current year of the receipt of $608,000 related to the refund of an equipment deposit and $74,000 primarily related to higher operating costs for personnel, R&D, travel, and changes in working capital.

Indebtedness

None.

Other Contractual Obligations

None.

Off-Balance Sheet Arrangements

There were no off-balance sheet arrangements for the three and six months ended February 28, 2026 and 2025.

Recently Issued Accounting Standards

For more information regarding recent accounting standards and their impact to our results of operations and financial position, see “Note 2- Summary of Significant Accounting Policies” to our Financial Statements.

Critical Accounting Policies

Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements required the use of estimates and judgments that affect the reported amounts of our assets, liabilities, and expenses. Management bases estimates on historical experience and other assumptions it believes to be reasonable under the circumstances and evaluates these estimates on an on-going basis. Actual results may differ from these estimates. There have been no significant changes to the critical accounting policies and estimates included in our Quarterly Report on Form 10-Q for the three months ended February 28, 2026.

Related Party Transactions

For a discussion of our Related Party Transactions, see “Note–6 - Transactions With Related Persons” to our Financial Statements included elsewhere in this Quarterly Report on Form 10-Q.

Corporate Information

SolarWindow Technologies, Inc., a Nevada corporation, was incorporated in 1998. The Company’s executive offices are located at 9375 E Shea Blvd., Suite 107-B, Scottsdale AZ 85260. The Company’s telephone number is (800) 213-0689. Our Internet address is www.solarwindow.com. We make available free of charge through our Internet website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission (“SEC”). The information accessible through our website is not a part of this Quarterly Report on Form 10-Q.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in interest rates and foreign currency exchange rates. We do not hold or issue financial instruments for trading purposes.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

Our Acting Principal Executive Officer and Principal Financial Officer (“Management”), after evaluating the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of February 28, 2026, have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Management does not expect that the Company’s disclosure controls or the Company’s internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. We will conduct periodic evaluations of our internal controls to enhance, where necessary, our procedures and controls.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation described above that occurred during the three months ended February 28, 2026 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K filed with the SEC on November 13, 2025, for the year ended August 31, 2025, which could materially affect our business, financial condition, financial results, or future performance. There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended August 31, 2025.

Item 6. Exhibits

Exhibit No.	Description of Exhibit
31.1	Certification of the Principal Executive Officer Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

31.2	Certification of the Principal Financial Officer Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

32.1	Certification of the Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

101.INS	Inline XBRL Instance Document**
101.SCH	Inline XBRL Taxonomy Extension Schema Document**
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document**
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document**
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document**
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document**
104	Cover Page Interactive Data File (embedded within the Inline XBRL Document)

____________________

*Filed herewith

** Furnished herewith. XBRL (eXtensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SolarWindow Technologies, Inc.

By:	*/S/Amit Singh*
	Amit Singh
	Chief Executive Officer
	(Principal Executive Officer)
Date:	April 9, 2026

By:	*/S/ Justin Frere*
	Justin Frere, CPA
	Interim Chief Financial Officer
	(Principal Financial Officer)
Date:	April 9, 2026

SolarWindow Technologies, Inc. 10-Q